Barry Richard — SEC insider filings
SEC reporting owner CIK 1562371. 28 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-08-06 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 20 legs across 13 filings — 1,679,862 shares, $9,218,730 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 30,000 shares, $4,754,972 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 26,860 shares @ $158.43 ($4,255,430) in Sarepta Therapeutics, Inc., filed 2020-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | Director | 10 | 2 legs · 50,000 sh · $3,940,500 | 2 legs · 30,000 sh · $4,754,972 | 17 |
| FILANA THERAPEUTICS, INC. (FLNA) | President & CEO, Director | 17 | 18 legs · 1,629,862 sh · $5,278,230 | — | 8 |
| MIMEDX GROUP, INC. (MDXG) | Director | 1 | — | — | 1 |
Insider filings — Barry Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 44,851 @ $0.52 | EDGAR |
| 2026-11-19 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 132,926 @ $0.48 | EDGAR |
| 2026-11-18 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 440,206 @ $0.47 | EDGAR |
| 2026-10-01 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 206,813 @ $0.90 · Purchase (P): 100,000 @ $0.92 | EDGAR |
| 2026-09-30 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 93,091 @ $0.84 | EDGAR |
| 2026-06-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 16,875 | EDGAR |
| 2025-11-24 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 150,000 @ $2.76 | EDGAR |
| 2025-11-20 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 73,385 @ $2.75 | EDGAR |
| 2025-09-23 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 7,172 @ $2.28 | EDGAR |
| 2025-09-22 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 5,400 @ $2.13 · Purchase (P): 185,233 @ $2.24 · Purchase (P): 400 @ $2.25 · Purchase (P): 46,908 @ $2.29 | EDGAR |
| 2025-05-19 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 12,350 @ $32.63 · Option exercise (M): 12,350 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 9,746 @ $25.18 · Option exercise (M): 10,500 @ $13.71 · Option exercise (M): 9,746 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,383 @ $0 · Grant/award (A): 4,792 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-04-25 | 4 | CASSAVA SCIENCES INC (SAVA) | Option exercise (M): 176,085 @ $22 · Grant/award (A): 117,390 (derivative) @ $0 · Option exercise (M): 117,390 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,846 @ $0 · Grant/award (A): 3,679 (derivative) @ $0 | EDGAR |
| 2023-11-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Purchase (P): 10,000 @ $78.81 · Purchase (P): 40,000 @ $78.81 | EDGAR |
| 2023-08-23 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 1,906 @ $16.80 · Purchase (P): 16,571 @ $16.65 | EDGAR |
| 2023-05-08 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 20,000 (derivative) @ $22.34 · Grant/award (A): 5,000 (derivative) @ $22.34 | EDGAR |
| 2023-03-08 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 11,565 @ $26.13 · Purchase (P): 77,276 @ $25.76 | EDGAR |
| 2023-03-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,523 @ $0 · Grant/award (A): 3,257 (derivative) @ $0 | EDGAR |
| 2022-08-25 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 36,159 @ $23.79 | EDGAR |
| 2022-03-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,953 @ $0 · Grant/award (A): 5,077 (derivative) @ $0 | EDGAR |
| 2021-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,726 @ $0 · Grant/award (A): 5,518 (derivative) @ $0 | EDGAR |
| 2020-08-07 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Sale (S): 26,860 @ $158.43 · Sale (S): 3,140 @ $159.09 | EDGAR |
| 2020-08-06 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 38,135 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1562371 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs